TY - JOUR
T1 - Graft-related disease progression in dura mater graft-associated CreutzfeldtJakob disease
T2 - A cross-sectional study
AU - Sakai, Kenji
AU - Hamaguchi, Tsuyoshi
AU - Noguchi-Shinohara, Moeko
AU - Nozaki, Ichiro
AU - Takumi, Ichiro
AU - Sanjo, Nobuo
AU - Nakamura, Yosikazu
AU - Kitamoto, Tetsuyuki
AU - Saito, Nobuhito
AU - Mizusawa, Hidehiro
AU - Yamada, Masahito
PY - 2013
Y1 - 2013
N2 - Objectives: Details of abnormal prion protein (PrPSc) propagation in the human central nervous system (CNS) are unclear. To assess the spread of PrPSc through the human CNS, we evaluated dura mater graft-associated Creutzfeldt-Jakob disease (dCJD) cases focusing on sites of grafting and dCJD pathological subtypes. Design: A cross-sectional study. Setting: nationwide surveillance data of human prion diseases in Japan over the past 12 years were applied for the study. Participants: Clinical data were obtained from 84 dCJD patients. Outcome measures: The clinical courses in cases of dCJD were analysed according to the grafting sites (supratentorial and infratentorial groups) and the pathological subtypes (non-plaque and plaque types). Results: Of the 84 cases of dCJD in this study, 36 (43%) were included in the supratentorial group and 39 (46%) were included in the infratentorial group. As initial manifestations, vertigo (p=0.007) and diplopia (p=0.041) were significantly more frequent in the infratentorial group than in the supratentorial group. During their clinical course, cerebellar signs appeared more frequently in the infratentorial group than in the supratentorial group (p=0.024). In the non-plaque type cases (n=53), the infratentorial group developed vertigo more frequently than the supratentorial group (p=0.017); moreover, cerebellar signs appeared more frequently in the infratentorial group (p=0.014). However, there was no significant difference between groups in the plaque type (n=18). Conclusions: The high frequency of clinical manifestations related to brain stem and cerebellar dysfunction in the non-plaque type dCJD with infratentorial grafting suggests that PrPSc commonly shows direct propagation into the CNS from contaminated dura mater grafts.
AB - Objectives: Details of abnormal prion protein (PrPSc) propagation in the human central nervous system (CNS) are unclear. To assess the spread of PrPSc through the human CNS, we evaluated dura mater graft-associated Creutzfeldt-Jakob disease (dCJD) cases focusing on sites of grafting and dCJD pathological subtypes. Design: A cross-sectional study. Setting: nationwide surveillance data of human prion diseases in Japan over the past 12 years were applied for the study. Participants: Clinical data were obtained from 84 dCJD patients. Outcome measures: The clinical courses in cases of dCJD were analysed according to the grafting sites (supratentorial and infratentorial groups) and the pathological subtypes (non-plaque and plaque types). Results: Of the 84 cases of dCJD in this study, 36 (43%) were included in the supratentorial group and 39 (46%) were included in the infratentorial group. As initial manifestations, vertigo (p=0.007) and diplopia (p=0.041) were significantly more frequent in the infratentorial group than in the supratentorial group. During their clinical course, cerebellar signs appeared more frequently in the infratentorial group than in the supratentorial group (p=0.024). In the non-plaque type cases (n=53), the infratentorial group developed vertigo more frequently than the supratentorial group (p=0.017); moreover, cerebellar signs appeared more frequently in the infratentorial group (p=0.014). However, there was no significant difference between groups in the plaque type (n=18). Conclusions: The high frequency of clinical manifestations related to brain stem and cerebellar dysfunction in the non-plaque type dCJD with infratentorial grafting suggests that PrPSc commonly shows direct propagation into the CNS from contaminated dura mater grafts.
UR - http://www.scopus.com/inward/record.url?scp=84885346398&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885346398&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2013-003400
DO - 10.1136/bmjopen-2013-003400
M3 - Article
C2 - 23975105
AN - SCOPUS:84885346398
SN - 2044-6055
VL - 3
JO - BMJ Open
JF - BMJ Open
IS - 8
M1 - e003400
ER -